These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis. Lekva T; Bollerslev J; Kristo C; Olstad OK; Ueland T; Jemtland R J Clin Endocrinol Metab; 2010 Jan; 95(1):246-55. PubMed ID: 19875485 [TBL] [Abstract][Full Text] [Related]
6. [Glucocorticoid-induced osteoporosis: recent findings]. Angeli A; Osella G; Reimondo G; Terzolo M Ann Ital Med Int; 2000; 15(1):47-55. PubMed ID: 10842891 [TBL] [Abstract][Full Text] [Related]
8. Disturbed bone marrow adiposity in patients with Cushing's syndrome and glucocorticoid- and postmenopausal- induced osteoporosis. Sørensen NN; Andreasen CM; Jensen PR; Hauge EM; Bollerslev J; Delaissé JM; Kassem M; Jafari A; Diaz-delCastillo M; Andersen TL Front Endocrinol (Lausanne); 2023; 14():1232574. PubMed ID: 37881495 [TBL] [Abstract][Full Text] [Related]
9. Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone disease. Ferrari P Best Pract Res Clin Endocrinol Metab; 2003 Dec; 17(4):575-89. PubMed ID: 14687590 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of impaired growth: effect of steroids on bone and cartilage. Olney RC Horm Res; 2009 Nov; 72 Suppl 1():30-5. PubMed ID: 19940493 [TBL] [Abstract][Full Text] [Related]
11. Cushing's syndrome and bone mineral density: lowest Z scores in young patients. van der Eerden AW; den Heijer M; Oyen WJ; Hermus AR Neth J Med; 2007 Apr; 65(4):137-41. PubMed ID: 17452762 [TBL] [Abstract][Full Text] [Related]
12. Pathogenic mechanisms of glucocorticoid-induced osteoporosis. Chen M; Fu W; Xu H; Liu CJ Cytokine Growth Factor Rev; 2023 Apr; 70():54-66. PubMed ID: 36906448 [TBL] [Abstract][Full Text] [Related]
13. Osteopathy in mild adrenal Cushing's syndrome and Cushing disease. Frara S; Allora A; di Filippo L; Formenti AM; Loli P; Polizzi E; Tradati D; Ulivieri FM; Giustina A Best Pract Res Clin Endocrinol Metab; 2021 Mar; 35(2):101515. PubMed ID: 33795196 [TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid-induced osteoporosis in children: impact of the underlying disease. Leonard MB Pediatrics; 2007 Mar; 119 Suppl 2():S166-74. PubMed ID: 17332238 [TBL] [Abstract][Full Text] [Related]
15. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone. Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508 [TBL] [Abstract][Full Text] [Related]
16. [Skeletal changes in Cushing's syndrome and in iatrogenic hypercortisonism]. Ellegast H Wien Klin Wochenschr; 1966 Feb; 78(7):125-6. PubMed ID: 5983042 [No Abstract] [Full Text] [Related]
17. Adverse effects of corticosteroids on bone metabolism: a review. Mitra R PM R; 2011 May; 3(5):466-71; quiz 471. PubMed ID: 21570035 [TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids. Warriner AH; Saag KG Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):510-6. PubMed ID: 24468753 [TBL] [Abstract][Full Text] [Related]